Publication | Closed Access

Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose–dense sequential adjuvant chemotherapy

Breast OncologyBreast Cancer PatientsRandomized StudyMedicinePrognostic ValuePathologyBreast CancerCancer TreatmentOncologyRadiation OncologyCancer Growth